Wednesday
SESSION 32: CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
Location: Grand Ballroom West, 3rd Floor
Moderators:Ron Waksman, MD / Michael R. Jaff, DO  
SESSION 32 SCHEDULE
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
7:42 AM - 7:47 AM Update On The Status Of Renal Denervation For Hypertension: It Is Here To Stay: Where Is It Going: Status Of The Radiofrequency Denervation SPYRAL HTN-OFF MED RCT (vs Sham) And Other Catheter-Based Ablative And Ultrasound Methods (The RADIANCE II RCT Findings)
  Presenter(s):Eric A. Secemsky, MD, MSc  
Location: Grand Ballroom West, 3rd Floor
7:48 AM - 7:53 AM Multiorgan Denervation For Treatment Of Hypertension, Diabetes And Metabolic Syndrome: How To Do It
  Presenter(s):Horst Sievert, MD  
Location: Grand Ballroom West, 3rd Floor
7:54 AM - 7:59 AM A Precision Medicine Approach To Managing Pediatric Renovascular Hypertension: How Can Medical And Open Surgical Treatment Control It
  Presenter(s):Dawn M. Coleman, MD, FACS  
Location: Grand Ballroom West, 3rd Floor
OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT
8:00 AM - 8:05 AM How Does The Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment
  Presenter(s):Katherine A. Gallagher, MD  
Location: Grand Ballroom West, 3rd Floor
8:06 AM - 8:11 AM How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem
  Presenter(s):Juan C. Parodi, MD  
Location: Grand Ballroom West, 3rd Floor
8:12 AM - 8:17 AM When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matters
  Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS  
Location: Grand Ballroom West, 3rd Floor
8:18 AM - 8:23 AM Update On Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities
  Presenter(s):Panos Kougias, MD, MSc  
Location: Grand Ballroom West, 3rd Floor
8:24 AM - 8:29 AM How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why Its Important In Deciding To Treat ACS Patients Non-Invasively
  Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS  
Location: Grand Ballroom West, 3rd Floor
8:30 AM - 8:35 AM Secondary Prevention Of Vascular Disease And Its Complication With PCSK9 Inhibitors; When They Should Be Used And When Not: How Well Does The New Oral PCSK9 (Inhibitor MK-01616 Work)
  Presenter(s):Roxana Mehran, MD  
Location: Grand Ballroom West, 3rd Floor
8:36 AM - 8:41 AM How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk
  Presenter(s):Ron Waksman, MD  
Location: Grand Ballroom West, 3rd Floor
8:42 AM - 8:50 AM Panel Discussion
8:50 AM - 9:06 AM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32
previous next